
Mid Europa's Alpha Medical buys Euromedic’s laboratories
Alpha Medical, a provider of laboratory testing services backed by Mid Europa Partners, has acquired the Czech laboratory business of medical services provider Euromedic.
Alpha Medical, which was bought by Mid Europa from Penta Investments last year, took over six laboratories and 15 collection points from Montagu portfolio company Euromedic.
Euromedic is partly owned by Montagu, which backed the firm in 2008 in a joint buyout alongside Merrill Lynch Global Private Equity and Ares Life Sciences from Warburg Pincus and GE Capital Equity Investments. Montagu provided €70m of equity towards the transaction.
The medical services provider stepped away from its laboratories business in order to focus on diagnostic imaging and cancer detection, as well as treatment.
Company
Euromedic Labs is made up of six laboratories and 15 collection points across the Czech Republic, all of which had been acquired by Euromedic from 2007 onwards.
The laboratories engage in routine and specialised tests in biochemistry, microbiology, immunology, haematology and pathology. The firm aims to perform more than 7 million tests overall this year.
People
Peter Lednicky is the CEO of Alpha Medical. Paweł Padusiński, Jan Krzewiński and Artur Sieńczewski worked on the deal for Mid Europa. Dimitris Moulavasilis is CEO of Euromedic.
Advisers
Equity – Deloitte (Corporate finance); Weil Gotshal & Manges (Legal);
Kinstellar (Legal).
Vendor – Ernst & Young (Corporate finance); Clifford Chance (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater